Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$26.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 16 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 94 business days late.
The 28 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Aug 5 |
| JAZZ |
| Jazz Pharmaceuticals plc |
| AGRANT |
| 1,605 |
| — |
| — |
| +7.5% |
| Open the original filing on SEC.gov |
| Jun 15 | ZBIO | Zenas BioPharma, Inc. | AGRANT◆ | 18,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | BIOA | BioAge Labs, Inc. | AGRANT◆ | 22,000 | — | — | — | Open the original filing on SEC.gov |
| May 21 | VERA | Vera Therapeutics, Inc. | AGRANT◆ | 17,084 | — | — | — | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | CCONV◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | CCONV◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | CCONV◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | PBUY | 882,353 | $17.00 | $15M | +75.3% | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | PBUY | 192,647 | $17.00 | $3.3M | +8.0% | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | CCONV | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | CCONV | 1.2M | — | — | +94.7% | Open the original filing on SEC.gov |
| Feb 5 | MANE | Veradermics, Inc | CCONV | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Feb 3 | MANE | Veradermics, Inc | AGRANT◆ | 45,131 | — | — | — | Open the original filing on SEC.gov |
| Dec 11, 2025 | VERA | Vera Therapeutics, Inc. | PBUY | 5,882 | $42.50 | $250K | — | Open the original filing on SEC.gov |
| Oct 9, 2025 | ZBIO | Zenas BioPharma, Inc. | PBUY | 11,990 | $20.85 | $250K | — | Open the original filing on SEC.gov |
| Oct 9, 2025 | ZBIO | Zenas BioPharma, Inc. | PBUY | 105,265 | $19.00 | $2M | +6.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | JAZZ | Jazz Pharmaceuticals plc | JOTHER | 5,000 | — | — | -18.9% | Open the original filing on SEC.gov |
| Aug 8, 2025 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 1,805 | $111.25 | $200.8K | -6.4% | Open the original filing on SEC.gov |
| Aug 7, 2025 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 3,507 | — | — | +14.2% | Open the original filing on SEC.gov |
| Jun 24, 2025 | VERA | Vera Therapeutics, Inc. | PBUY | 27,071 | $22.35 | $605.1K | +0.8% | Open the original filing on SEC.gov |
| Jun 24, 2025 | VERA | Vera Therapeutics, Inc. | PBUY | 13,536 | $22.35 | $302.6K | +0.8% | Open the original filing on SEC.gov |
| Jun 23, 2025 | VERA | Vera Therapeutics, Inc. | PBUY | 139,595 | $20.87 | $2.9M | +4.1% | Open the original filing on SEC.gov |
| Jun 23, 2025 | VERA | Vera Therapeutics, Inc. | PBUY | 69,798 | $20.87 | $1.5M | +4.1% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ZBIO | Zenas BioPharma, Inc. | AGRANT◆ | 18,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | BIOA | BioAge Labs, Inc. | AGRANT◆ | 22,000 | — | — | — | Open the original filing on SEC.gov |
| May 14, 2025 | VERA | Vera Therapeutics, Inc. | AGRANT◆ | 14,000 | — | — | — | Open the original filing on SEC.gov |